Pittsburgh Liver Research Center
Our mission is
to enable and promote multidisciplinary research
in all aspects of liver health and disease
for improved clinical outcomes.
Fostering team science
and promoting collaborations across disciplines
liver website.jpg
SEM liver.png
phalloidin and DAPI staining in liver tissue.jpg
Regenerative Medicine
Chronic Liver Diseases
Special Interest Groups

PLRC Receives NIDDK-DDRCC Funding

It is our great pleasure to announce the successful funding of the Pittsburgh Liver Research Center (PLRC) by the NIH/NIDDK through a P30 mechanism. We are now one of the 20 NIDDK-designated Digestive Disease Research Core Centers and one of three that are liver focused. 

PLRC 2019 Pilot and Feasibility Recipients


Pictured left to right: Hossam Abdelsamed, PhD  •  Amir Borhani, MD  •  Andres Duarte-Roho, MD, DSc  •  Christian Fernandez, PhD  •  Zachary Freyberg, MD, PhD  •  Sungjin Ko, DVM, PhD  •  Anita McElroy, MD, PhD  •  Marlies Meisel, PhD  •  Vikrant Rachakonda, MD  •  Sadeesh Ramakrishnan, DVM, PhD  •  Jaideep Behari, MD, PhD  •  Reben Raeman, PhD

To read about the Pilot and Feasibility projects, please visit the Grants page by clicking here.


Upcoming Events

Seminars and events. Know what's coming.

See what's coming

PLRC Meet and Greet
4:30pm to 7:30pm

University Club
PLRC Seminar Series - Dr. Josep Llovet
12:00pm to 1:00pm

S120 BST
Liver Seminar - Dr. Al Sirica
12:00pm to 1:00pm

Important National Meetings

AASLD The Liver Meeting 2019

November 8-12, 2019
Boston, Massachusetts

Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2019

November 15-16, 2019
Las Vegas, Nevada

Faculty Spotlight - Dr. Michael Nalesnik

Dr. Nalesnik is an active service pathologist with 37 years of experience in transplantation pathology and serves as Medical Director of the Clinical Histology and Immunocytochemistry Laboratory . He has made contributions in the area of posttransplant lymphoproliferative disorders, recently headed a UNOS-based initiative to establish a systematic manner of dealing with the problem of transmission risk of organ donor-associated malignancy, and currently chairs the Malignancy subcommittee of the WHO/CNT Global NOTIFY library website.
Dr. Nalesnik’s specific research interests center on posttransplant lymphoproliferative disorders that often occur in association with Epstein-Barr virus infection. He is also involved with the problem of liver neoplasia in transplant candidates/patients and provides support for investigations into donor organ preservation.